Pazopanib for inoperable and metastatic malignant granular cell tumour (all ages)

Document first published:
Page updated:
Topic:
Publication type:
,

This policy statement is to confirm that pazopanib is not recommended as a treatment option for inoperable and metastatic malignant granular cell tumours (all ages).